Article Details
Retrieved on: 2025-09-13 04:22:43
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
... monoclonal antibodies, including latozinemab and AL101 to treat neurodegenerative diseases. The company was founded in 2013 and is headquartered ...
Article found on: www.aaii.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here